A review of current phase III clinical trials of plaque psoriasis: under-representation of nonwhite participants and need for reform
Br J Dermatol
.
2021 Feb;184(2):348-350.
doi: 10.1111/bjd.19468.
Epub 2020 Sep 24.
Authors
V D Reddy
1
,
B A Myers
1
,
S Y Chan
1
,
Q G Thibodeaux
1
,
N D Brownstone
1
,
T Bhutani
1
,
W Liao
1
,
J C Lester
1
,
J Y Koo
1
Affiliation
1
Department of Dermatology, University of California, San Francisco, CA, USA.
PMID:
32767747
DOI:
10.1111/bjd.19468
No abstract available
Publication types
Letter
Review
MeSH terms
Antibodies, Monoclonal
Clinical Trials, Phase III as Topic
Humans
Psoriasis* / drug therapy
Treatment Outcome
Substances
Antibodies, Monoclonal